KM-391
KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
KM-391 is a serotonin reuptake inhibitor which was under development for the treatment of autism but was never marketed. It is taken by mouth.
See also
Zolmitriptan § Social deficits and aggression
Text derived from https://en.wikipedia.org/w/index.php?oldid=1256621640 under CC BY-SA 4.0; modifications have been made.